ID   HS-RMS-1
AC   CVCL_A791
DR   Wikidata; Q54896289
RX   PubMed=10853028;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=10853028).
CC   Derived from site: In situ; Left gluteal muscle; UBERON=UBERON_0002000.
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=10853028; DOI=10.3892/ijo.17.1.119;
RA   Sonobe H., Takeuchi T., Taguchi T., Shimizu K., Furihata M.,
RA   Ohtsuki Y.;
RT   "A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1,
RT   exhibiting MyoD1 and myogenin.";
RL   Int. J. Oncol. 17:119-125(2000).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//